GEODE CAPITAL MANAGEMENT, LLC - BIODELIVERY SCIENCES INTL IN ownership

BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 84 filers reported holding BIODELIVERY SCIENCES INTL IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of BIODELIVERY SCIENCES INTL IN
ValueSharesWeighting
Q4 2021$5,345,000
-15.3%
1,724,411
-1.4%
0.00%0.0%
Q3 2021$6,312,000
+5.8%
1,748,634
+4.9%
0.00%0.0%
Q2 2021$5,967,000
-6.0%
1,666,947
+2.7%
0.00%0.0%
Q1 2021$6,346,000
+10.9%
1,623,258
+19.1%
0.00%0.0%
Q4 2020$5,724,000
+15.6%
1,363,082
+2.7%
0.00%0.0%
Q3 2020$4,951,000
-11.0%
1,327,566
+4.0%
0.00%0.0%
Q2 2020$5,566,000
+24.5%
1,276,827
+8.3%
0.00%0.0%
Q1 2020$4,470,000
-68.6%
1,179,499
-47.6%
0.00%0.0%
Q4 2019$14,218,000
+236.8%
2,249,908
+124.4%
0.00%0.0%
Q3 2019$4,221,000
-8.0%
1,002,844
+1.6%
0.00%0.0%
Q2 2019$4,588,000
+60.6%
986,833
+83.0%
0.00%0.0%
Q1 2019$2,857,000
-25.4%
539,378
-47.9%
0.00%0.0%
Q4 2018$3,830,000
+167.3%
1,035,240
+102.2%
0.00%
Q3 2018$1,433,000
-2.9%
511,992
+2.3%
0.00%
Q2 2018$1,476,000
+41.9%
500,341
+8.2%
0.00%
Q1 2018$1,040,000
-23.8%
462,5330.0%0.00%
Q4 2017$1,364,0000.0%462,5330.0%0.00%
-100.0%
Q3 2017$1,364,000
+5.3%
462,5330.0%0.00%0.0%
Q2 2017$1,295,000
+44.9%
462,533
-1.7%
0.00%
Q1 2017$894,000
+8.8%
470,726
+0.1%
0.00%
Q4 2016$822,000
-6.2%
470,068
+44.9%
0.00%
Q3 2016$876,000
+22.2%
324,492
+6.6%
0.00%
Q2 2016$717,000
-25.9%
304,323
+1.5%
0.00%
-100.0%
Q1 2016$968,000
-31.9%
299,783
+1.0%
0.00%0.0%
Q4 2015$1,421,000
-12.0%
296,716
+2.1%
0.00%0.0%
Q3 2015$1,615,000
-22.4%
290,605
+11.1%
0.00%0.0%
Q2 2015$2,081,000
-22.3%
261,534
+2.6%
0.00%
-50.0%
Q1 2015$2,677,000
-7.9%
255,010
+5.4%
0.00%0.0%
Q4 2014$2,907,000
-26.7%
241,893
+4.2%
0.00%
-33.3%
Q3 2014$3,966,000
+51.5%
232,142
+7.0%
0.00%
+50.0%
Q2 2014$2,618,000
+48.2%
216,971
+3.6%
0.00%
+100.0%
Q1 2014$1,767,000
+159.5%
209,424
+81.0%
0.00%
Q4 2013$681,000
+10.0%
115,708
+1.6%
0.00%
Q3 2013$619,000
+37.9%
113,933
+3.1%
0.00%
Q2 2013$449,000110,4950.00%
Other shareholders
BIODELIVERY SCIENCES INTL IN shareholders Q3 2018
NameSharesValueWeighting ↓
Founders Capital Management 1,000$3,0000.00%
Close Asset Management Ltd 7,500$23,0000.00%
IFP Advisors, Inc 250$1,0000.00%
View complete list of BIODELIVERY SCIENCES INTL IN shareholders